ClearPoint Neuro, Inc. (CLPT)
11.69
+0.22
(+1.92%)
USD |
NASDAQ |
May 07, 10:43
ClearPoint Neuro Cash from Investing (Quarterly) : 1.088M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -14.85M |
| Stryker Corp. | -185.00M |
| Abbott Laboratories | -20.32B |
| Accuray, Inc. | -5.596M |
| Plus Therapeutics, Inc. | -1.077M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.08M |
| Cash from Financing (Quarterly) | 19.56M |
| Free Cash Flow | -24.45M |
| Free Cash Flow Per Share (Quarterly) | -0.4222 |
| Free Cash Flow to Equity (Quarterly) | -34.62M |
| Free Cash Flow to Firm (Quarterly) | -11.43M |
| Free Cash Flow Yield | -7.39% |